NCT00186277: Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer |
|
|
| Completed | 2 | 10 | US | Oxaliplatin, Eloxatin, Taxotere, Docetaxel | Stanford University, Sanofi-Synthelabo | Bladder Cancer | 12/06 | 12/06 | | |
CORGI, NCT01016639: Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer |
|
|
| Completed | 1/2 | 106 | Europe | oxaliplatin, capecitabine, radiotherapy | Lund University Hospital, Roche Pharma AG, Sanofi-Synthelabo | Stomach Cancer, Gall Bladder Cancer, Bile Ductus Cancer, Pancreas Cancer, Colorectal Cancer | 07/07 | 07/09 | | |
